Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Doxorubicin | [1] Doxorubicin Doxorubicin (Doxorubicina) | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
(Doxorubicin hydrochloride, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE LIPOSOME),Doxorubicin (Doxorubicin) 💬 | - | - | [3] 26 26, 28, 331 💬
|
2 | Doxorubicin hydrochloride | [1] Doxorubicin Doxorubicin (Doxorubicina) | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
(Doxorubicin hydrochloride, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE LIPOSOME),Doxorubicin (Doxorubicin) 💬 | - | - | [3] 26 26, 34, 331 💬
|
3 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | [1] Doxorubicin Doxorubicin (Doxorubicina) | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
(Doxorubicin hydrochloride, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE LIPOSOME),Doxorubicin (Doxorubicin) 💬 | - | - | [1] 65 65 💬
|
4 | Liposomal doxorubicin | [1] Doxorubicin Doxorubicin (Doxorubicina) | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
(Doxorubicin hydrochloride, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE LIPOSOME),Doxorubicin (Doxorubicin) 💬 | - | - | [1] 331 331 💬
|
5 | SP-101 and doxorubicin cohort 1 | [1] SP-101 SP-101 | - | - | - | [1] 299 299 💬
|
6 | SP-101 and doxorubicin cohort 2 | [1] SP-101 SP-101 | - | - | - | [1] 299 299 💬
|